Decision intelligence - A diagnosis before a prescription
An AI-native analysis engine that ingests fifty-plus signals about a business, finds where it is actually bleeding, and sequences the work: stabilize first, grow second.
- Client
- Multi-unit operator seeking a turnaround
- Service
- Decision intelligence

The pattern
A business in trouble rarely has one problem. It has fifteen, tangled together, and no way to tell which one is upstream of the others. The instinct — the one most consultants are paid to indulge — is to start with growth: more leads, more spend, more locations. But growth applied to an unstable foundation doesn't fix the instability. It scales it.
The harder, more valuable question is sequence. Of everything that's wrong, what has to be true first? Which fix unlocks the next three? Where is the business quietly bleeding in a way that no single dashboard reveals because the signal is spread across finance, staffing, demand, and operations at once?
The expensive part was never the analysis. It was affording someone senior enough to do it, for long enough to be sure.
This kind of cross-cutting diagnosis used to be the exclusive domain of expensive advisory firms — months of engagement, a team of analysts, a price tag that put it permanently out of reach for the small and mid-sized businesses that needed it most. The work was real. The economics simply didn't reach down-market.
The approach
We built an engine that does the reading. It ingests fifty-plus signals about a business — margins by line, cohort retention, fixed-versus-variable cost structure, demand seasonality, staffing ratios, working-capital position, channel performance, and more — and treats them not as separate dashboards but as a single connected system. The model's job is not to surface metrics. It's to find the order: what is upstream, what is downstream, what is bleeding now versus what is merely suboptimal.
The output is not a report. It's a sequenced plan with two clear phases. Stabilize — the small set of changes that stop active loss and make the foundation load-bearing. Grow — the investments that compound, but only deployed once the base can hold the weight. The discipline is in the refusal to recommend growth before the foundation is sound.
What we built
- An ingestion layer that normalizes fifty-plus business signals into one connected model
- AI-native analysis that finds causal ordering, not just correlations
- A two-phase output — stabilize, then grow — with each recommendation tied to the signal that justifies it
- A re-run loop, so the diagnosis updates as the business changes rather than aging on a shelf
The result
The shift was in what the owner could now afford to know. A senior, cross-functional diagnosis that would once have meant a major, costly advisory engagement became something a single mid-sized operator could run, act on, and re-run as conditions changed. The plan told them not just what was wrong, but what to fix first — and crucially, what not to invest in yet.
| Outcome | Before | After |
|---|---|---|
| Diagnosis depth | Single-metric dashboards | Fifty-plus signals, one connected model |
| Sequencing | "Grow" by default | Stabilize first, grow on a sound base |
| Access | A costly advisory engagement | A tool a mid-sized operator can run |
This is the work AI made newly possible. The analytical judgment was always valuable; what changed is that we can now deliver it at a price that reaches the businesses that need it most. The diagnosis comes before the prescription — and now both fit inside a real budget.
We had been told to grow for two years. What we needed was someone to tell us where we were losing money and in what order to fix it. That ordering was the whole game.
